Del Trezise

Del is a NED and provides key industry insight on product and application development for the SemaCyte platform. Del co-founded Essen Biosciences and spearheaded the commercial development of the Incucyte® platform. He is also a Technology scout at Sartorius, and a NED at Axol Biosciences and ELRIG.